![Characteristics and outcomes of Embolic Stroke of Undetermined Source according to stroke severity - Ioannis Leventis, Kalliopi Perlepe, Dimitrios Sagris, Gaia Sirimarco, Davide Strambo, Georgios Georgiopoulos, Ashraf Eskandari, Efstathia Karagkiozi ... Characteristics and outcomes of Embolic Stroke of Undetermined Source according to stroke severity - Ioannis Leventis, Kalliopi Perlepe, Dimitrios Sagris, Gaia Sirimarco, Davide Strambo, Georgios Georgiopoulos, Ashraf Eskandari, Efstathia Karagkiozi ...](https://journals.sagepub.com/cms/10.1177/1747493020909546/asset/images/large/10.1177_1747493020909546-fig3.jpeg)
Characteristics and outcomes of Embolic Stroke of Undetermined Source according to stroke severity - Ioannis Leventis, Kalliopi Perlepe, Dimitrios Sagris, Gaia Sirimarco, Davide Strambo, Georgios Georgiopoulos, Ashraf Eskandari, Efstathia Karagkiozi ...
![Pharmaceuticals | Free Full-Text | Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives | HTML Pharmaceuticals | Free Full-Text | Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00658/article_deploy/html/images/pharmaceuticals-14-00658-g002.png)
Pharmaceuticals | Free Full-Text | Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives | HTML
![Pharmaceuticals | Free Full-Text | Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives | HTML Pharmaceuticals | Free Full-Text | Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00658/article_deploy/html/images/pharmaceuticals-14-00658-g001-550.jpg)